Sign in
4

Changes in Ownership

Evofem Biosciences, Inc. Filed Acc 0001618835-20-000003

Chief Financial Officer sold 3,352 shares at $6.05 ($20,280)

From the SEC's structured data for this filing

Trades in this filing

File Justin J. · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-01-02 Sale : show line 1 in the form −3,352 $6.05 $20,280 178,899 D
Open-market sales · 3,352 sh · avg $6.05 · $20,280
Loading xslF345X03/wf-form4_157834125799228.xml…